Mira Pharmaceuticals, Inc. Acquires Shares of Telomir Pharmaceuticals, Inc.

Mira Pharmaceuticals, Inc. has acquired 3,521,127 shares of common stock of Telomir Pharmaceuticals, Inc. This acquisition was made in connection with Mira Pharmaceuticals' acquisition of SKNY Pharmaceuticals, Inc. The shares are held directly by Mira Pharmaceuticals, Inc., and the transaction was reported on September 29, 2025. The filing was signed by Erez Aminov, CEO of Telomir Pharmaceuticals, Inc., on October 3, 2025. This filing is a Form 3, which is used to report initial beneficial ownership of securities.